Jasper Therapeutics (JSPR) Other Non-Current Assets (2020 - 2026)

Jasper Therapeutics has reported Other Non-Current Assets for 7 years, with the latest figure at $43000.0 in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 89.69% year-over-year to $43000.0 in Q2 2026; TTM through Jun 2026 was $43000.0, a 89.69% decrease from a year earlier, with the FY2025 full-year figure at $417000.0, down 49.15% from the prior year.
• Other Non-Current Assets was $43000.0 for Q2 2026 at Jasper Therapeutics, down from $417000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $3.4 million in Q1 2022, with the low at $43000.0 in Q2 2026.
• Average Other Non-Current Assets over 5 years is $1.0 million, with a median of $759000.0 recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets surged 161.35% in 2024, then slumped 89.69% in 2026.
• Over 5 years, Other Non-Current Assets stood at $759000.0 in 2022, then soared by 76.94% to $1.3 million in 2023, then tumbled by 38.94% to $820000.0 in 2024, then slumped by 49.15% to $417000.0 in 2025, then plunged by 89.69% to $43000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $43000.0 (Q2 2026), $417000.0 (Q4 2025), and $417000.0 (Q3 2025), per Business Quant data.